Simcor

From Self-sufficiency
Jump to: navigation, search
Simcor
File:Niacinstr.png
File:Simvastatin.svg
Combination of
Niacin n/a
Simvastatin Statin
Clinical data
Pregnancy
category
  • US: X (Contraindicated)
Routes of
administration		 Oral
Legal status
Legal status
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Simcor (Abbott) is a drug combination of the statin drug Simvastin and an extended release form of niacin used for the treatment of dyslipidemia. It was approved by the FDA on February 15, 2008.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />
GI tract
Liver
Niacin and derivatives (HDL and LDL)
Blood vessels
Combinations
Other

M: MET

mt, a/u/y/n/h, r/g/c/p/i, f/s/l/o, m

au/y/n/h, rgcp/i, f/s/l/o, m, epon

meds(A16, C10),intm(a/u/y/n/h, r/g/c/p/i, f/s/o)


30px This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it.
  1. ↑ "Drugs.com, Abbott Receives FDA Approval for Simcor (Niaspan / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management". Retrieved 2008-03-15. 
Retrieved from "http://ssf.f15ijp.com/wiki/index.php?title=Simcor&oldid=29167"